A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

Fact checked by Nick Blackmer The Centers for Disease Control and Prevention (CDC) has expanded the RSV vaccine ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

July is Chronic Disease Awareness Month and serves as an important reminder to take charge of your health and get informed about potential health risks. Dr. Samantha Picking, ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

Each year, almost 200,000 adults 65 and older are hospitalized due to RSV, and an estimated 14,000 of those cases result in ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.